One of these mechanisms is upregulation of other pro-angiogenic HIF-1 targets such as fibroblast growth factors (FGFs), as evidenced by sustained inhibition of tumor growth and angiogenesis by concomitant FGF and VEGF targeting [183]. The gene discussed is VEGFA; the disease is neoplasm.